Cytostatic and immunologic activity of 5-mercaptouracil desoxyriboside in the management of multiple superficial basal cell epitheliomas.
D000963:Antimetabolites / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000276:immunology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003857:Deoxyuridine / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D006968:Hypersensitivity, Delayed; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology; D013438:Sulfhydryl Compounds / Q000627:therapeutic use*; D014529:Uridine / Q000627:therapeutic use*
D000963:Antimetabolites; D004273:DNA, Neoplasm; D013438:Sulfhydryl Compounds; D005472:Fluorouracil; D003857:Deoxyuridine; D014529:Uridine